Genex Pharmaceutical

GENX · OTC

$0.0001−$0.0001 (−50.00%)TodayMarket closed · May 14, 11:42 AM ET

No price history for this range.

About GENX

Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company is headquartered in Tianjin, Tianjin and currently employs 86 full-time employees. The company went IPO on 2006-05-23. The Company’s main business is engaged in producing and distributing Reconstituted Bone Xenograft (RBX). The RBX is a medical device that accelerates bone healing. The firm distributes its medical devices to hospitals as well as other medical device customers that are not hospitals.

Employees: 86
Headquarters: Tianjin, Tianjin
Listed: May 23, 2006
Sector: Health Care
Industry: Health Care Equipment & Supplies

Leadership

Genex Pharmaceutical executives
Name	Title	Since	Age
Song Fuzhi	—	2004	58
Zhang Shuli	—	—	48
Sufen Ai	—	—	35

Similar companies

Companies in the same industry as Genex Pharmaceutical

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.